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A seroprevalence study of Human immunodeficiency virus (HIV) infection in new patients attending the eye clinic of LAUTECH  
Teaching Hospital in Osogbo, Osun State, Nigeria showed that twenty-nine patients 2.7%) were positive to HIV1.  No patient was 
positive to HIV 2. There were 21 males (72.4%) and 8 females (27.6%). The clinical diagnosis in the HIV positive patients was as 
shown in Table 1. Cataract was found in nine cases (31.03%), herpes zoster 4 (13.79%), glaucoma, optic atrophy (non-
glaucomatous) and corneal abscess were responsible for 3 (10.35%) of cases each; presbyopia, bacterial conjunctivtis 2 (6.89%) 
while maculopathy, orbital cellulitis and adherent leucoma were found in 1 (3.45%) patient each. These findings suggest that, 
patients with ocular disorders and who are otherwise healthy looking may infact be HIV seropositive and as such it may be 
necessary to observe all rules relating to HIV transmission so as to prevent occupational exposure and cross infection in our clinics 
and operating theatres. Necessary measures to reduce occupational HIV infection and post exposure treatment if exposure occurs 
are discussed. 
 




An estimated 42 million people worldwide are now 
infected with the human immunodeficiency virus 
(HIV), (1) the causative agent of the acquired 
immunodeficiency syndrome compared with 
30million people that were infected in 1997(2). 
Ninety per cent (90%) of these live in developing 
countries.  
Reports from the 14th International AIDS 
Conference (Barcelona, Spain) project that, in the 
absence of an expanded prevention effort, there 
will be 45 million new HIV infections by 2010. It 
is estimated that 29 million of these infections 
could be prevented with the expansion of existing 
prevention strategies (3). Ocular involvement in 
HIV infection has been reported in large numbers 
in industrialized countries with comparatively little 
report from developing countries where most 
affected people live. In the health care setting, 
exposures occur through needle sticks or cuts from 
other sharp instruments contaminated with an 
infected patient’s blood (percutaneous exposures) 
or, less frequently, after infected blood gets into a 
worker’s open cut or a mucous membrane such as 
the eyes or inside the nose.  
Some people with HIV remain asymptomatic and 
these constitute an important source of 
transmission of the virus (4). HIV has been isolated 
from the tear fluid, conjunctiva of HIV positive but 
asymptomatic individuals (5).  There have also 
been reports of health care workers who 
seroconverted following infected blood splash onto 
their mucous membranes and non-intact skin (6). 
The conjunctiva and cornea have also been 
recognized as a potential route for transmission of 
infection in the operating room personne (7). These 
findings show that there is a risk of being infected 
while treating an unsuspected HIV positive patient. 
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In a study in the Eastern part of Nigeria, 5.3% of 
new patients seen in the eye clinic were HIV 
positive (8).  
This study will estimate the prevalence of HIV 
infection among eye patients in this area to be able 
to plan and provide preventive measures that will 
reduce cross infection within the staff and patients. 
It will also attempt to discuss the various measures 
necessary to reduce occupational HIV infection 
and post exposure treatment if there is exposure. 
 
MATERIALS AND METHOD 
This was a prospective study conducted in the eye 
clinic of LAUTECH Teaching Hospital and a 
private specialist clinic in Osogbo, Osun State, 
Nigeria. One thousand and sixty six (1066) new 
patients seen between July 2004 and May 2007 
were included in the study. Osun state is situated in 
South Western Nigeria. It is bounded on the West 
and North West by Oyo State, on the East by Ondo 
State and on the South by Ogun State. Only new 
patients were included in the study. They were 
investigated using enzyme linked immuno sorbent 
assay (ELISA) technique after thorough pretest 
counseling. They were tested for both HIV 1 and 2 
using immunocomb. Those who tested positive had 
confirmatory test using immunocomb II HIV 1 
AND 2 Comb firm. Other information obtained 
included the age, sex, diagnosis and whether or not 
the patients needed surgery. Data obtained were 
presented in tables.  
 
RESULTS 
One thousand and sixty six (1066) new patients 
were studied. Males predominate with a male to 
female ratio of 1.2: 1. Their ages ranged between 6 
months and 90 years with a mean age of 47.53 
years.  
Twenty-nine patients (2.7%) were positive to 
HIV1. No patient was positive to HIV 2. There 
were 21 males (72.4%) and 8 females (27.6%). The 
clinical diagnosis in the HIV positive patients was 
as shown in Table 1. Cataract was found in nine 
cases (31.03%), herpes zoster 4 (13.79%), 
glaucoma, optic atrophy (non-glaucomatous) and 
corneal abscess were responsible for 3 (10.35%) of 
cases each; presbyopia, bacterial   conjunctivtis 2 
(6.89%) while maculopathy, orbital cellulitis and 
adherent leucoma were found in 1 (3.45%) patient 
each.  
    
TABLE 1: HIV Positive Cases By Diagnosis 
 Diagnosis                           no of cases    % 
 Cataract                              9.00              31.03 
Herpes zoster                      4.00              13.79 
Glaucoma                            3.00             10.35 
Maculopathy                        1.00             3.45 
Non-glaucomatous  
Optic atrophy                       3.00             10.35 
Orbital cellulites                  1.00             3.45 
Corneal abscess                   3.00             10.35 
Adherent leucoma                1.00            3.45 
Presbyopia                           2.00             6.89 
Bacterial conjunctivitis       2.00              6.89 
Total                                   29.00             100.00 
                                     
  
DISCUSSION 
According to the World Health Organization, the 
estimated total number of HIV-positive people 
worldwide has increased from 39.4 million in 2004 
to 40.3 million and by the end of year 2005, there 
were between 1.7M to 4.2M Nigerians living with 
HIV/AIDS.  
 
Reports from the 14th International AIDS 
Conference (Barcelona, Spain) project that, in the 
absence of an expanded prevention effort, there 
will be 45 million new HIV infections by 2010. It 
is estimated that 29 million of these infections 
could be prevented with the expansion of existing 
prevention strategies (3).  
This study shows that patients with eye disorders 
may have been infected with HIV as twenty nine 
(2.7%) out of 1066 new patients who attended the 
eye clinic for one thing or the other were HIV 
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positive. This is lower than what was obtained in 
the eastern part of this country (8) and a previous 
study in this hospital (9) possibly due to the larger 
population in this study (1066) compared with 76 
and 241 in those studies.  Several workers who 
studied non-ophthalmic patients had prevalence 
rates of 5.4% in sexually transmitted disease and 
antenatal clinic attendees in Oyo State  (10), and 
2.4% in tuberculous patients in Lagos (11). 
 
Male to female ratio in HIV positive patients   was 
1.2: 1. This contrasts with Nwosu’s (8)  study in 
which all HIV positive patients were males. The 
ages ranged between 20 and 61 years. 13 (44.8%) 
patients were aged 20-40 years. This supports 
previous findings in Western Nigeria (10) where 
the highest prevalence for HIV was found between 
20 –39years. The 4 patients that had herpes zoster 
ophthalmicus were HIV positive and they were 
aged 22 and 43 years. This further confirms 
previous reports that Herpes zoster ophthalmicus in 
apparently healthy young adults is a marker of HIV 
in Africa (12).   
 
Nine patients (37%) were cataract surgical patients 
and 3 patients had glaucoma. This is in contrast to 
the study in the Eastern part of Nigeria8 where all 
the surgical patients were HIV negative. 
It is therefore necessary that ophthalmic workers 
must observe all the rules for preventing HIV 
transmission during routine patient examination 
and surgical operations (5, 13). As a matter of fact, 
it may be necessary to screen routinely all patients 
going for surgery for HIV. 
 
Young adults with Herpes zoster infection must be 
assumed positive to HIV until proven otherwise 
and rules for preventing HIV transmission to staff 
and other patients must be observed. 
 
The increasing number of HIV positive people who 
are asymptomatic in this environment also calls for 
high index of suscipicion and so appropriate steps 
need be taken to avoid cross infection in clinical 
practice.  
 
PREVENTIVE STRATEGIES  
All healthcare personnel should assume that 
blood and other body fluids (such as tears 
especially when contaminated with discharges or 
blood) from all patients are potentially infectious. 
They should therefore follow infection control 
precautions at all times. These precautions 
include:  
1. The routine use of barriers (such as gloves 
and/or goggles) when anticipating contact 
with blood or body fluids  
2. Washing hands and other skin surfaces 
immediately after contact with blood or 
body fluids, and 
3. The careful handling and disposing of 
sharp instruments during and after use. 
There are safety devices which, if used 
properly may reduce the risk of exposure 
to HIV. Many percutaneous injuries are 
related to sharps disposal. Strategies for 
safer disposal, including safer design of 
disposal containers and placement of 
containers, are being developed. 
Using universal precautions, along with personal 
protective equipment, engineering controls and 
other work practice controls, reduces employee 
exposure to blood borne pathogens. However, 
personal protective equipment may provide a 
barrier to protect skin and mucous membranes 
from contact with blood and other potentially 
infectious material, but most of them such as 
gloves can easily be penetrated by needles. There is 
therefore the need to prevent needle stick injuries. 
These are caused by unsafe needle devices rather 
than careless use by health care workers.14 Safer 
needle devices that incorporate engineering 
controls have been shown to significantly reduce 
the incidence of accidental needle stick injuries and 
exposure to potentially fatal blood borne illnesses. 
The term, "safer needle device," is broad and 
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includes many different types of devices such as 
those that have a protective shield over the needle, 
self re-sheathing needles, blunted surgical needles) 
and those that do not use needles at all. The 
common feature of effective safer needle devices is 
that they reduce the risk of needle stick injuries for 
health care workers before, during, or after use 
through built-in safety features. Although all major 
medical device manufacturers market devices with 
safety features, no standard criteria exist for 
evaluating the safety claims of these features. 
Employers implementing needle stick prevention 
programs should evaluate the effectiveness of 
various devices in their specific settings. Also, the 
introduction of new devices must be accompanied 
by intensive staff education and training. 
Despite precautions and safety devices, 
occupational exposures to HIV will continue to 
occur. Planning for such incidents and knowing 
how to treat exposed healthcare workers are 
paramount.   
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